We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Premaitha | LSE:NIPT | London | Ordinary Share | GB00BN31ZD89 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 9.10 | 9.00 | 9.20 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMNIPT
RNS Number : 4052L
Premaitha Health PLC
18 July 2017
TR-1: Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)(i) ------------------------------------------------------------------------------------------------------------ 1a. Identity of the issuer Premaitha Health plc or the underlying issuer of existing shares to which voting rights are attached(ii) : -------------------------------------------------- -------------------------------------------------------- 1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate) ------------------------------------------------------------------------------------------------------------ Non-UK issuer ----------------------------------------------------------------------------------------- ----------------- 2. Reason for the notification (please mark the appropriate box or boxes with an "X") ------------------------------------------------------------------------------------------------------------ An acquisition or disposal of voting rights ----------------------------------------------------------------------------------------- ----------------- An acquisition or disposal of financial instruments X ----------------------------------------------------------------------------------------- ----------------- An event changing the breakdown of voting rights ----------------------------------------------------------------------------------------- ----------------- Other (please specify)(iii) : ----------------------------------------------------------------------------------------- ----------------- 3. Details of person subject to the notification obligation(iv) Name Life Technologies Limited, a company incorporated in Scotland with company number SC083107 City and country of registered office (if applicable) 4. Full name of shareholder(s) (if different from 3.)(v) ------------------------------------------------------------------------------------------------------------ Name -------------------------------------------------- -------------------------------------------------------- City and country of registered office (if applicable) -------------------------------------------------- -------------------------------------------------------- 5. Date on which the threshold 11 July 2017 was crossed or reached(vi) : -------------------------------------------------- -------------------------------------------------------- 6. Date on which issuer notified 13 July 2017 (DD/MM/YYYY): -------------------------------------------------- -------------------------------------------------------- 7. Total positions of person(s) subject to the notification obligation ------------------------------------------------------------------------------------------------------------ % of voting % of voting Total of Total number rights attached rights through both in % of voting to shares financial (8.A + 8.B) rights of (total of instruments issuer(vii) 8. A) (total of 8.B 1 + 8.B 2) --------------------- ------------------------- ------------------- ---------------- ------------------- Resulting 25.92% (based 321,218,279 situation on current (based on on the date share capital) current on which and 20.88% share capital) threshold (based on and 398,795,385 was crossed so-enlarged (based on or reached share capital) so-enlarged share capital) --------------------- ------------------------- ------------------- ---------------- ------------------- Position 16.92% (based of previous on current notification share capital) (if and 14.47% applicable) (based on so-enlarged share capital). --------------------- ------------------------- ------------------- ---------------- ------------------- 8. Notified details of the resulting situation on the date on which the threshold was crossed or reached(viii) ---------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares ---------------------------------------------------------------------------------------------------------------------- Class/type Number of voting rights(ix) % of voting rights of shares ISIN code (if possible) --------------------- Direct Indirect Direct Indirect (Art 9 of (Art 10 of (Art 9 of (Art 10 of Directive Directive Directive Directive 2004/109/EC) 2004/109/EC) 2004/109/EC) 2004/109/EC) (DTR5.1) (DTR5.2.1) (DTR5.1) (DTR5.2.1) ------------------- ------------------------- ------------------ ------------------------------ ---------------- SUBTOTAL 8. A --------------------- --------------------------------------------- ------------------------------------------------ B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a)) ---------------------------------------------------------------------------------------------------------------------- Type of financial Expiration Exercise/ Number of voting % of voting instrument date(x) Conversion rights that rights Period(xi) may be acquired if the instrument is exercised/converted. --------------------- ----------------------- ------------------ -------------------------------- ---------------- SUBTOTAL 8. B 1 ------------------ -------------------------------- ---------------- B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b)) ---------------------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Physical Number % of voting financial date(x) Conversion or cash of voting rights instrument Period settlement(xii) rights (xi) ------------------- ------------------------- ---------------- --------------------- ----------- ---------------- Warrants 11 December Exercisable [Physical] 20,325,204 8.9% (based 2023 up to 11 on current December share capital) 2023 and 7.07% (based on so-enlarged share capital) ------------------- ------------------------- ---------------- --------------------- ----------- ---------------- Warrants 11 December Exercisable [Physical] 17,094,018 7.5% (based 2023 up to 11 on current
December share capital) 2023 and 5.95% (based on so-enlarged share capital) ------------------- ------------------------- ---------------- --------------------- ----------- ---------------- Warrants 11 December Exercisable [Physical] 16,913,319 5.27% (based 2023 up to 11 on current December share capital) 2023 and 4.5% (based on so-enlarged share capital) ------------------- ------------------------- ---------------- --------------------- ----------- ---------------- Warrants 11 December Exercisable [Physical] 28,938,797 9% (based 2023 up to 11 on current December share capital) 2023 and 7.26% (based on so-enlarged share capital) ------------------- ------------------------- ---------------- --------------------- ----------- ---------------- SUBTOTAL 83,271,338 25.92% based 8.B.2 on current share capital) and 20.88% (based on so-enlarged share capital) --------------------- ----------- ---------------- 9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X") Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer(xiii) Full chain of controlled undertakings through which X the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity(xiv) (please add additional rows as necessary) --------------------------------------------------------------- --------------------- Name(xv) % of voting % of voting Total of both rights if it rights through if it equals equals or is financial instruments or is higher higher than if it equals than the notifiable the notifiable or is higher threshold threshold than the notifiable threshold ------------------ ---------------- ----------------------- ----------------------- Thermo Fisher 25.92% based Scientific Inc. on current share capital) and 20.88% (based on so-enlarged share capital) ------------------ ---------------- ----------------------- ----------------------- Thermo Fisher 25.92% based Scientific Life on current share Holdings Limited capital) and 20.88% (based on so-enlarged share capital) ------------------ ---------------- ----------------------- ----------------------- 10. In case of proxy voting, please identify: -------------------------------------------------------------------------------------- Name of the proxy holder ------------------------------------ ------------------------------------------------ The number and % of voting rights held ------------------------------------ ------------------------------------------------ The date until which the voting rights will be held ------------------------------------ ------------------------------------------------ 11. Additional information(xvi) -------------------------------------------------------------------------------------- Place of completion London, United Kingdom -------------------- ----------------------- Date of completion 11 July 2017 -------------------- -----------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUWVURBKABAAR
(END) Dow Jones Newswires
July 18, 2017 09:02 ET (13:02 GMT)
1 Year Premaitha Chart |
1 Month Premaitha Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions